Skip to content
The Policy VaultThe Policy Vault

Venclexta (venetoclax tablets)Cigna

Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma

Initial criteria

  • Patient is age ≥ 18 years; AND
  • Patient has tried at least one systemic regimen.

Approval duration

1 year